The UK trial is the next step in the development of a vaccine to protect people against MERS \u2013 a deadly viral illness with no current vaccines and the potential to cause a pandemic.
The review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.
The MBRRACE-UK Collaboration, jointly led by Nuffield Department of Population Health\u2019s National Perinatal Epidemiology Unit (NPEU) and the University of Leicester\u2019s The Infant Mortality and Morbidity Studies (TIMMS) research group, has published a \u2018State of the Nation\u2019 report on perinatal deaths in babies born in the UK in 2021.
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. Launched on the 4th of August 2023, the clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
A comprehensive new analysis has found that nicotine e-cigarettes, varenicline and cytisine are the most effective options currently available for helping smokers quit long-term (going at least six months without smoking).
Polycystic ovarian syndrome (PCOS), a hormonal condition which affects how the ovaries work, is thought to affect 20% of women worldwide. Yet despite how common the condition is, and the serious effect it has on women\u2019s health, researchers still aren\u2019t completely sure what causes PCOS \u2013 let alone how best to manage and treat the condition.
Researchers at Nuffield Department of Population Health have found that having poor metabolic health was related to an increased risk of developing dementia in a study of more than 176,000 individuals.
A new study led by the Mead Group in the MRC Weatherall Institute of Molecular Medicine (Radcliffe Department of Medicine) has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant haematopoietic stem cells.
High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including \u2018brain fog\u2019, giving a major clue as to one cause of their symptoms: blood clots.
Professor Herman Waldmann FMedSci (Sir William Dunn School of Pathology) is one of four Oxford University researchers recognised today by the Royal Society.
A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
Researchers at Oxford University's Nuffield Department of Primary Care Health Sciences have developed a new tool to predict people\u2019s risks of getting oesophageal cancer in the next ten years.
In a pan-cancer analysis spanning 24 different cancer types, Department of Oncology researchers shed light on the critical role of SETD2 in tumourigenesis.
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures. The method, published in Nature Nanotechnology, employs innovative nanopore technology to identify structural variations at the single-molecule level, even deep within long protein chains.
The liver transplant team at the Royal Free Hospital (RFH) has successfully recruited the first liver to be used in a revolutionary new study \u2014 looking at whether fat can be removed from donor livers to make them suitable for transplantation. The study is being run from the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford.
Research into the onset and progression of diseases affecting musculoskeletal soft tissues could be greatly advanced using novel 3D models say researchers in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, in a review published in The Lancet Rheumatology.
Professor Sir Aziz Sheikh has been appointed to succeed Professor Richard Hobbs CBE as Nuffield Professor of Primary Care Health Sciences and Head of Department from August 2024.
Containment measures introduced to prevent the spread of SARS-CoV-2 resulted in a sustained reduction in the transmission of certain bacteria that cause diseases such as meningitis, sepsis and pneumonia, according to a new study published in The Lancet Digital Health by the Invasive Respiratory Infection Surveillance (IRIS) Consortium.
![\"57-year-old](\"https://www.medsci.ox.ac.uk/news/oxford-and-liverpool-scientists-launch-new-vaccine-trial-for-middle-east-respiratory-syndrome-mers/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n